Gelatin microcarriers as an effective adipose-derived stem cells delivery strategy in osteoarthritis treatment

Xiaoyun Peng1, Wenjing Song1, Zijian Yan1

  • 1School of Materials Science and Engineering, South China University of Technology, Guangzhou 510006, China; National Engineering Research Center for Tissue Restoration and Reconstruction, Guangzhou 510006, China; Key Laboratory of Biomedical Engineering of Guangdong Province, South China University of Technology, Guangzhou 510006, China; Key Laboratory of Biomedical Materials and Engineering of the Ministry of education, South China University of Technology, Guangzhou 510006, China; Innovation Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, China.

Insights

Gelatin microcarriers enhance adipose-derived stem cell (ADSC) therapy for osteoarthritis (OA) by improving cell function and retention. Smaller microcarriers demonstrated superior therapeutic effects in an OA rat model, offering a promising delivery strategy.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Orthopedics

Background:

  • Osteoarthritis (OA) treatment with stem cells (SCs) faces challenges in cell retention and paracrine function.
  • Effective SC culture and delivery systems are crucial for enhancing OA therapy outcomes.

Purpose of the Study:

  • To investigate gelatin microcarriers of different sizes as scaffolds for culturing adipose-derived stem cells (ADSCs) for OA therapy.
  • To evaluate the impact of microcarrier size on ADSC paracrine function and therapeutic efficacy in an OA model.

Main Methods:

  • Adipose-derived stem cells (ADSCs) were cultured on gelatin microcarriers (180 μm and 320 μm) and compared to standard culture plates.
  • The secretome of ADSCs on microcarriers was analyzed for its effects on macrophages and chondrocytes.
  • ADSCs, with and without microcarriers, were injected into a rat OA model to assess therapeutic effects, including friction reduction.

Main Results:

  • ADSCs cultured on microcarriers exhibited enhanced paracrine function compared to those on culture plates.
  • Microcarrier-supported ADSCs effectively reduced the coefficient of friction at the cartilage interface.
  • Smaller microcarriers (180 μm) delivering low-dose ADSCs showed superior therapeutic effects in the OA rat model.

Conclusions:

  • Gelatin microcarriers serve as effective scaffolds for ADSC culture, improving their therapeutic potential for OA.
  • Microcarrier-based delivery systems, particularly smaller ones, offer a promising strategy to enhance stem cell retention and efficacy in OA treatment.